R
Regenosine is developing a disease-modifying regenerative therapy that utilizes stem cell technology to repair cartilage damage in osteoarthritis patients. This approach aims to reduce pain and improve joint function, addressing the limitations of current symptomatic treatments.
Updated 20 months ago
Funding
$25K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NFunding rounds are not available yet.
Founders
Product
Features
- Regenosine is developing a disease-modifying regenerative therapy that utilizes stem cell technology to repair cartilage damage in osteoarthritis patients. This approach aims to reduce pain and improve joint function, addressing the limitations of current symptomatic treatments.